|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61K 47/34 | |||
| A61K 47/02 |
| (11) | Number of the document | 3432916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17777119.3 |
| Date of filing the European patent application | 2017-09-13 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/051394 |
| Date | 2017-09-13 |
| (87) | Number | WO 2018/053021 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662394009 P | 2016-09-13 | US |
| (72) |
ABIAD, Maurice, US
DANI, Bhas, US
SHALAEV, Evgenyi, US
|
| (73) |
Allergan, Inc.,
2525 Dupont Drive, Irvine, California 92612,
US
|
| (54) | STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |
| STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |